Zanidatamab

Tax included
Zanidatamab (ZW25) is a humanised, bispecific monoclonal antibody targeting 2 distinct HER2 epitopes (ECD2 and ECD4). Zanidatamab has anti-tumour activity.
HY-P99380

Data sheet

Size
Multiple sizes
Reactivity
EGFR
Application
Cancer-Kinase/protease
CAS
2169946-15-8